메뉴 건너뛰기
American Journal of Health-System Pharmacy
Volumn 58, Issue 2, 2001, Pages 134-139
Regulation of the compounding of positron emission tomography drugs
Author keywords

Compounding; Control, quality; Drugs, investigational; Good Manufacturing Practices; Pharmacy; Radiopharmaceuticals; Regulations; Standards; Tom ography; United States Pharmacopeia
Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;
EID: 0035862929     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.2.134     Document Type: Review
Times cited : (3)
References (19)
  • 1
    • 0006357760 scopus 로고
    • Draft guidelines on the manufacture of positron emission tomography radiopharmaceutical drug products; availability
    • (1995) Fed Regist , vol.60 , pp. 10593-10594
  • 2
    • 0006300920 scopus 로고    scopus 로고
    • Guidance for industry: Current good manufacturing practices for positron emission tomographic (PET) drug products; availability
    • (1997) Fed Regist , vol.62 , pp. 19580-19581
  • 3
    • 52649170097 scopus 로고    scopus 로고
    • Positron emission tomography
    • Food and Drug Administration Modernization Act of 1997. PL 105-115, Sec 121
  • 4
    • 84870395257 scopus 로고    scopus 로고
    • Definitions
    • Federal Food, Drug, and Cosmetic Act. Sec 201 (ii)
    • (1998)
  • 6
    • 84898425783 scopus 로고    scopus 로고
    • Pharmacy compounding
    • Federal Food, Drug, and Cosmetic Act. Sec 503A
  • 7
    • 4243628276 scopus 로고    scopus 로고
    • Adulterated drugs and devices
    • Federal Food, Drug, and Cosmetic Act. Sec 501(a) (2)(B)
    • (1998)
  • 8
    • 4243660125 scopus 로고    scopus 로고
    • New drugs
    • Federal Food, Drug, and Cosmetic Act. Sec 505
    • (1998)
  • 9
    • 4243703801 scopus 로고    scopus 로고
    • Misbranded drugs and devices
    • Federal Food, Drug, and Cosmetic Act. Sec 502(f) (1)
    • (1998)
  • 10
    • 0032407610 scopus 로고    scopus 로고
    • Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine
    • (1998) J Nucl Med , vol.39 , pp. 2190-2192
    • Silberstein, E.B.1
  • 11
    • 0001049524 scopus 로고    scopus 로고
    • Positron emission tomography drug products; safety and effectiveness of certain PET drugs for specific indications
    • (2000) Fed Regist , vol.65 , pp. 12999-13010
  • 14
    • 0006332076 scopus 로고    scopus 로고
    • Radiopharmaceuticals for positron emission tomography - Compounding (chapter 823)
    • The United States pharmacopeia, 24th rev., and The national formulary, 19th ed. Rockville, MD: United States Pharmacopeial Convention, Inc.
    • (2000) , pp. 1988-1990
  • 15
    • 0006263401 scopus 로고    scopus 로고
    • Methionine C 11 injection
    • The United States pharmacopeia, 24th rev., and The national formulary, 19th ed. Rockville, MD: United States Pharmacopeial Convention, Inc.
    • (2000) , pp. 309
  • 16
    • 0006301553 scopus 로고    scopus 로고
    • Fludeoxyglucose F 18 injection
    • The United States pharmacopeia, 24th rev., and The national formulary, 19th ed. Rockville, MD: United States Pharmacopeial Convention, Inc.
    • (2000) , pp. 733
  • 17
    • 0006357380 scopus 로고    scopus 로고
    • Ammonia N 13 injection
    • The United States pharmacopeia, 24th rev., and The national formulary, 19th ed. Rockville, MD: United States Pharmacopeial Convention, Inc.
    • (2000) , pp. 1189
  • 18
    • 0032110916 scopus 로고    scopus 로고
    • HCFA's coverage instructions for lung PET
    • News
    • (1998) J Nucl Med , vol.39
  • 19
    • 0006357041 scopus 로고    scopus 로고
    • Positron emission tomography (PET) scans
    • Medicare coverage issues manual. Transmittal No. 13, Section 50-36. Washington, DC: Health Care Financing Administration; 1999 Apr.
    • (1999)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.